Lataa...
Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer
Bevacizumab combined with cytotoxic chemotherapy is the backbone of metastatic colorectal cancer (mCRC) therapy; however, its treatment efficacy is hampered by therapeutic resistance. Therefore, understanding the mechanisms underlying bevacizumab resistance is crucial to increasing the therapeutic e...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771567/ https://ncbi.nlm.nih.gov/pubmed/29342159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0189582 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|